Ryan Richardson brings more than 20 years of experience in the healthcare and finance industries to his role of Chief Strategy Officer of BioNTech. Ryan joined BioNTech in 2018 as SVP Corporate Development & Strategy and was appointed to Chief Strategy Officer and a Member of the Management Board in 2020. Prior to joining BioNTech in 2018, Ryan was an Executive Director and Vice President in the Global Healthcare Investment Banking team at J.P. Morgan in London, where he advised companies in the biotech and life sciences industry on cross-border M&A, equity, and debt capital financings. Earlier in his career, Ryan worked for five years as a Management Consultant to biopharmaceutical companies in the U.S. and Europe, focusing on strategic and operational projects in the areas of commercial strategy, pricing and market access, new product planning, and R&D transformation. Ryan holds an International MBA from the University of Chicago Booth School of Business, an MSc from the London School of Economics, and a BSc in Biology from the University of Kansas.